← All trials
NCT03684811
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 1, 2018
- Primary completion
- Sep 1, 2021
- Completion date
- Apr 1, 2022
- First posted
- —
- Last posted
- —
- Enrollment
- 200
- Arms / groups
- 5 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Forma Therapeutics, Inc.Lead sponsor
- Forma Therapeutics, Inc.Study director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.